Navigation Links
Regenesis Biomedical Advances Corporate Strategy by Appointing Vice President of Marketing
Date:5/1/2008

g them to replicate and to produce natural growth factors and other gene expression products, which facilitate reduction of the pain and edema associated with post-operative wound healing in soft tissues. We believe Provant is effective, economical, and easy-to-use.

About Regenesis Biomedical

Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant Wound Therapy System. Our customers include health care facilities and providers that serve patients with wounds being treated by acute care hospitals, long- term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and wound care clinics.

Contact:

Regenesis Biomedical, Inc.

Media: Scott Robey, VP Marketing robey@regenesisbiomedical.com

Clinicians: Rick Isenberg, MD, VP Clinical Affairs

isenberg@regenesisbiomedical.com

Investors: Virginia Rybski, Acting President

rybski@regenesisbiomedical.com

http://www.regenesisbiomedical.com

480-970-4970


'/>"/>
SOURCE Regenesis Biomedical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
2. Boston Biomedical Research Institute Maintains Baa3 Rating from Moodys
3. SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
4. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
5. LifeNet Health(R) Unveils New Biomedical Spine Implant
6. MIT researcher addresses biomedical engineering challenges
7. mNEMOSCIENCE GmbH Announces Global Licensing Agreement With Aporo Biomedical
8. Bookham to Enter Biomedical Illumination Market
9. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
10. New NIST mini-sensor may have biomedical and security applications
11. BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 The human skin is ... as an important human body part. Similar to the liver, ... order to function, repair and grow. Recent reports from the ... supplements, is just as important as other life supporting organs. ... aid in skin cell reproduction, increase the appearance of skin, ...
(Date:6/18/2013)... WILMINGTON, Delaware , June 18, 2013 /PRNewswire/ ... to announce the release of the HELM biomolecular ... permissive open source MIT licence. HELM ... of a wide range of biomolecules (e.g. proteins, ... render existing small-molecule and sequence-based informatics methodologies impractical ...
(Date:6/18/2013)... The "Bioinformatics Market By Sector (Molecular Medicine, Agriculture, Research ... Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Global Forecasts ... and Opportunities in North America , ... Rest of World. Browse , ... 364 Pages and an in-depth Table ...
(Date:6/18/2013)... 18, 2013 Research ... the addition of the report " DNA ... to their offering.      (Logo: ... basics of human genome variations, development of ... and small sequencers are described as well ...
Breaking Biology Technology:Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
... today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique ... ... , , ... ...
... ... , ... March 11, 2010 -- ClearTrial, the leading provider of Clinical Trial Operations (CTO) software, ... Bank and Cowen & Company at CBI,s 2010 Accounting and Reporting Congress in Philadelphia, ...
... PHILADELPHIA and LONDON , March 11 Thomson Reuters today announced it has launched the highly anticipated Academic ... to data gathering and analytics to provide a one-of-a-kind resource to the global scholarly community. , ... ... ...
Cached Biology Technology:Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 2Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage 3ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 2ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 3Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 2Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project 3
(Date:6/16/2013)... group together and move around the body called ,chase ... by scientists at UCL. , Published in Nature ... that occurs when cancer cells interact with healthy cells in ... that cancer cells recruit healthy cells and use them to ... how it could be controlled to design new therapies against ...
(Date:6/15/2013)... drug approved in Europe to treat osteoporosis has now ... cells, even in cancers that have become resistant to ... study. , The findings, presented June 15, 2013, at ... that the drug bazedoxifene packs a powerful one-two punch ... cell growth, but also flags the estrogen receptor for ...
(Date:6/14/2013)... will collaborate with researchers from Oklahoma State University, ... of Tulsa to advance understanding of how socio-ecological ... and variability in the state. , Oklahoma ... $20 million National Science Foundation Experimental Program to ... innovative research over the next five years. ...
Breaking Biology News(10 mins):'Chase and run' cell movement mechanism explains process of metastasis 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2OU researchers collaborate on $20 million NSF EPSCoR grant 2OU researchers collaborate on $20 million NSF EPSCoR grant 3
... traditional approach to pharmaceutical design uses so-called "first ... ?to initiate various cellular cascades for the desired ... all levels of research, this approach has failed ... address this major global health problem. , Enter ...
... and twig bark are helping stop the spread of ... was brought into the United States in the 1800s ... had become an out-of-control pest, crowding native plants, such ... throughout the American West. , Agricultural Research Service (ARS) ...
... New York University and Rockefeller University have discovered ... to have key roles in gene regulation, can ... MicroRNAs are a recently discovered large class of ... sites in target messenger RNA to regulate their ...
Cached Biology News:Second messenger NAADP shows fast, dose-related impact on satiety cycle 2Second messenger NAADP shows fast, dose-related impact on satiety cycle 3Beneficial Beetles Battle Pesky Saltcedar 2NYU, Rockefeller researchers find complexity of regulation by microRNA genes 2
Purified anti-PXR...
Request Info...
Mouse monoclonal [2991] to C3a / C3a des Arg ( Abpromise for all tested applications). SwissProtID: P01024...
Rabbit polyclonal to NMDAR1 e/f/g/h ( Abpromise for all tested applications)....
Biology Products: